"Market access" Perceptions and factors...

A change in the pharmaceutical environment has occurred from previously only needing to convince regulators of a product's safety and efficacy to obtain marketing authorisation to now needing to satisfy the value perceptions of other stakeholders, including payers, to attain market access for products. 
There is thus the need to understand the concept of market access that may be defined as ‘the process that ensures the development and commercial availability of pharmaceutical products with appropriate value propositions, leading to their prescribing and to successful uptake decisions by payers and patients, with the ultimate goal of achieving profitability and best patient outcomes’. 

 Click sobre imagen para ampliar.

The aim of this research therefore was to explore the understanding of market access among various stakeholders and how their understanding of this concept could improve patient access to pharmaceutical products. (...)

 Conclusions 

The concept of market access is still poorly understood, and the definition varies depending on the stakeholders’ perspectives. 
The survey described here revealed that a good awareness of unmet need/burden of disease, clinical efficacy, choice of comparators, safety, and price were the most important factors influencing the development of a successful pharmaceutical product. For cost-effective products to be developed and made accessible to patients, there is a need for wider understanding of market access and the value perspectives of the various stakeholders. As proposed, a multi-perspective definition of market access is the process that ensures the development and commercial availability of pharmaceutical products with appropriate value propositions, leading to their prescribing and to successful uptake decisions by payers and patients, with the ultimate goal of achieving profitability and best patient outcomes. Thus, research is underway to determine whether and how involved payers and other stakeholders should be in the development of pharmaceutical products. This new research should not only define the stakeholders but also elucidate how they should be involved in the different stages of product development. (Más)